Candida Rebello, PhD, Post-doctoral Researcher at Pennington Biomedical Research Center, recently published an article in the journal Diabetes, Obesity and Metabolism, est. audience 6.1 million. Dr. Rebello was awarded a LA CaTS Pilot Award in 2018 funded by Pennington Biomedical titled "Clinical Safety and Pharmacokinetic Evaluation of Naringenin: Single Dose Escalation Randomized Double Blind Controlled Trial".
Click HERE to see the article "Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial".